Epristeride
also Aipuliete, Chuanliu, SKF-105657
5-alpha reductase inhibitor approved in China for enlarged prostate, used off-label for hair loss
Epristeride, sold under the brand names Aipuliete and Chuanliu, is a medication which is used in the treatment of enlarged prostate in China. It is taken by mouth.
Read “Epristeride” on Wikipedia · text from Wikipedia, CC BY-SA 4.0
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research 10
- 6-Substituted 3,4-Dihydro-naphthalene-2-carboxylic Acids: Synthesis and Structure-Activity Studies in a Novel Class of Human 5α Reductase Inhibitors
- Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5α-reductase isoform 2
- Comparative study of human steroid 5α-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride
- Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor
- Effect of Epristeride on the Expression of IGF-1 and TGF-β Receptors in Androgen-Induced Castrated Rat Prostate
- Effects of a new 5α reductase inhibitor (epristeride) on human prostate cell cultures
- The mechanism of epristeride against benign prostatic hyperplasia
- Reversible Long-Term Toxicity of Epristeride in Beagle Dogs
- Inhibition of regrowth of prostatic glandular cells by epristeride.
- Normal-phase high-performance liquid chromatographic determination of epristeride, a prostatic steroid 5α-reductase enzyme inhibitor, in human plasma
- 6-Substituted 3,4-Dihydro-naphthalene-2-carboxylic Acids: Synthesis and Structure-Activity Studies in a Novel Class of Human 5α Reductase Inhibitors
- Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing
- Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor
- Comparative study of human steroid 5α-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride
- [The clinical efficacy of epristeride in the treatment of benign prostatic hyperplasia].
- Effect of Epristeride on the Expression of IGF-1 and TGF-β Receptors in Androgen-Induced Castrated Rat Prostate
- Inhibition of regrowth of prostatic glandular cells by epristeride.
- Effect of epristeride on expression of TGF-beta receptor in rat prostatic epithelial cells in vitro.
- Atrophy and apoptosis in ventral prostate of rats induced by 5alpha-reductase inhibitor, epristeride.
- Inhibition of cultured rat prostatic epithelial cell growth by epristeride in vitro.
Posts 11
- European finasteride difference
- Epristeride instead of Finasteride?
- Finasteride alternative close to fda approval in the US
- Epristeride: Alternative to Finasteride and Dutasteride?
- Finasteride Alternatives that actually work?
- Epristeride (type 2) vs Finasteride (type 2 and 3)
- Type 2 ar inhibitors (new study)
- We need actual hair loss studies on Epristeride
- What more can I add to my regimen?
- New Hair Loss Treatment from Kintor Just Hit the Market: KX-826!
- PP-405 Phase 2/3 study has begun